Deliargyris Efthymios (CIK 1751617) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-08-08). Recent activity: Buy CTSO (70,000 shares), Buy CTSO (16,233 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-08 | Cytosorbents Corp (CTSO) | Chief Medical Officer | Buy | 70,000 | $0 |
| 2025-01-22 | Cytosorbents Corp (CTSO) | Chief Medical Officer | Buy | 16,233 | $16,233 |
Source: SEC Form 4 filings · as of 2025-08-08